Role of cyclooxygenase-2 in the prolonged regulation of renal function

Hypertension

Volumn 40, Issue 5, 2002, Pages 721-728

  Roig, Francisco ^a   Llinás, Maria T ^a   López, Ruth ^a   Salazar, F Javier ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Aldosterone; Cyclooxygenase; Hemodynamics; Nitric oxide; Prostaglandins; Renal blood flow; Renin; Sodium

Indexed keywords

ALDOSTERONE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NITRIC OXIDE; POTASSIUM; PROSTAGLANDIN; RENIN; SODIUM;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; GLOMERULUS FILTRATION RATE; HIGH SODIUM INTAKE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; METABOLITE; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE; SODIUM RESTRICTION; SODIUM URINE LEVEL; VASOCONSTRICTION;

ALDOSTERONE; ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOGS; FEMALE; GLOMERULAR FILTRATION RATE; INFUSIONS, INTRAVENOUS; ISOENZYMES; KIDNEY; KIDNEY FUNCTION TESTS; MODELS, ANIMAL; NITRIC OXIDE; POTASSIUM; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RENAL CIRCULATION; RENIN; SODIUM; SODIUM CHLORIDE; SODIUM, DIETARY; SULFONAMIDES; TIME FACTORS; VASOCONSTRICTION;

EID: 0036841202     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000036451.76323.29     Document Type: Article

References (30)

1. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase II is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 1994;94:2504-2510.
2. Jensen BL, Kurtz A. Differential regulation of renal cyclooxygenase mRNA by dietary salt intake. Kidney Int. 1997;52:1242-1249.
3. Yang T, Singh I, Pham H, Sun D, Smart A, Schnermann JB, Briggs JP. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol Renal Physiol. 1998;274:F481-F489.
4. Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol. 2001;281:F1-F11.
5. Harding P, Carretero OA, Beierwaltes WH. Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics. J Hypertens, 2000;18:1107-1113.
6. Black SC, Brideau C, Cirino M, Belley M, Chan CC, Rodger IW. Different effect of a selective cyclooxygenase-2 inhibitor versus indomethacin on renal blood flow in conscious volume-depleted dogs. J Cardiov Pharmacol. 1998;32:686-694.
7. Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther. 1999;66:76-84.
8. Swan SK, Rudy DW. Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Pinto MB, Dilzer SC, Obrda O, Ebel DL, Quan H, Larson PJ, Schwartz JI, Gertz BJ, Brater DC, Yao SL. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low salt diet: A randomized, controlled trial. Ann Intern Med. 2000:4:1-9.
9. Navar LG, Inscho EW, Majid DSA, Imig JD. Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76:425-436.
10. Gonzaléz JD, Llinás MT, Moreno C, Rodriguez F, Salazar FJ. Role of nitric oxide and prostaglandins in the long-term control of renal function. Hypertension. 1999:32:33-38.
11. Gónzalez JD, Llinás MT, Moreno C, Rodriguez F, Salazar FJ. Renal effects of prolonged cyclooxygenase inhibition when angiotensin II levels are elevated. J Cardiov Pharmacol. 2000;36:236-241.
12. Ruilope LM, Robles RG, Paya C, Rodicio JL, Romero JC. Effects of long-term treatment with indomethacin on renal function. Hypertension. 1986;8:677-684.
13. Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Intern. 1993:44:643-653.
14. Baylis C, Slangen B, Hussain S, Weaver C. Relationship between basal NO release and cyclooxygenase products in the normal rat kidney. Am J Physiol Regulatory Physiol. 1996:271:RI327-R1334.
15. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension. 1993;22:49-55.
16. Shultz PJ, Tolins JP. Adaptations to increased dietary salt intake in the rat: Role of endogenous nitric oxide. J Clin Invest. 1993;91:642-650.
17. Catella-Lawson F, Mcadam B, Morrison BW, Kapoor S, Kujubu D, Quan H, Gertz BJ. Fitzgerald GA. Effects of specific inhibition of cyclooxy-genase-2 on sodium balance, hemodynamic, and vasoactive eicosanoids. J Pharmacol Exper Therap. 1999;289:735-741.
18. Imig JD. Eicosanoid regulation of the renal vasculature. Am J Physiol Renal Physiol. 2000;279:F965-F981.
19. Smith WL, Garavito RM, DeWitt DL. Prostaglandins, endoperoxide H synthases (cyclooxygenase)-1, and 2. J Biol Chem. 1996;271:33157-33160.
20. Wolf K:Castrop H, Hartner A, Goppelt-Strübe, Hilgers KF, Kurtz A. Inhibition of the renin-angiotensin system upregulates cyclooxygenase-2 expression in the macula densa. Hypertension. 1999;34:503-507.
21. Stanfield KM., Khan KN Gralinski MR. Localization of cyclooxygenase isozymes in cardiovascular tissues of dogs treated with naproxen. Vet Immunol Immunopathol, 2001;80:309-314.
22. Dibona GF, Knopp UC. Neural control of renal function. Physiological Review. 1997;77:77-196.
23. Llinás, MT, López R, Rodríguez F, Roig F, Salazar FJ. Role of cyclooxygenase-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine. Am J Physiol Renal Physiol. 2001:281:F975-F982.
24. Carroll MA, Kemp R, Cheng MK, McGiff JC. Regulation of preglomerular microvascular 20-hydroxyeicosatetraenoic acid levels. Med Sci Monit. 2001;7:567-572.
25. Rodríguez F, Llinás MT, Moreno C, Salazar FJ. Role of Cyclooxygenase-2-derived Metabolites and NO in Renal Response to Bradykinin Hypertension. 2001;37:129-134.
26. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes, Proc Natl Acad Sci U S A. 1993;90:7240-7244.
27. Rodríguez F, Llinás MT, González JD, Rivera J, Salazar FJ. Renal changes induced by a COX-2 inhibitor during normal and low sodium intake. Hypertension. 2000;36:276-281.
28. Harris RC, Cheng H-F, Wang J-L, Zhang M-Z, McKanna JA. Interactions of the renin-angiotensin system and neuronal nitric oxide synthase in regulation of cyclooxygenase-2 in the macula densa. Acta Physiol Scand. 2000;168:47-51.
29. Díaz-Cazorla M, Pérez-Sala D, Lamas S. Dual effect of nitric oxide donors on COX-2 expression in human mesangial cells. J Am Soc Nephrol. 1999;10:943-952.
30. Henrion D, Dechaux E, Dowell FJ, Maclour J, Samuel J-L, Lévy BI, Michel J-B. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME-treated rats and its partial association with induction of cyclooxygenase-2. Br J Pharmacol. 1997;121:83-90.